Hilal Nakkaş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hilal Nakkaş has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Şeyma Kipel
ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ, TIP FAKÜLTESİ
5 shared publications - Tuba Ozdemir-Sanci
Department of Histology and Embryology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye
3 shared publications - Ayca Bilginoglu
Department of Biophysics, Faculty of Medicine, Ankara Yildirim Beyazit University, 06800 Ankara, Türkiye
2 shared publications - Belgin Can
Department of Histology and Embryology Ankara University Ankara Turkey
2 shared publications - Beyza Ecem Oz Bedir
Ankara Yildirim Beyazit Universitesi
2 shared publications - Adem Sancı
Ankara Etlik Şehir Hastanesi
1 shared publication
Latest Publications
- 16 November 2026
- Published by Springer Nature in Cytotechnology
- Vol. 79 (1)
SVIP knockdown alters UPS protein expression in human testicular embryonal carcinoma cells
- 16 November 2026
- Published by Springer Nature in Cytotechnology
- Vol. 79 (1)
SVIP knockdown alters UPS protein expression in human testicular embryonal carcinoma cells
- Open Access
- 1 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (10) , 1015
Tomentosin Potentiates Cisplatin-Induced Apoptosis and Modulates Proteostasis-Related Proteins in A549 Lung Cancer Cells
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the need for improved therapeutic strategies and adjunct treatment approaches. In this study, we investigated the anticancer effects of tomentosin in A549 cells and evaluated the cellular response to its combined exposure with cisplatin. Cell viability was assessed using the WST-1 assay in A549 and BEAS-2B cells. Apoptosis was evaluated by Annexin V-FITC/PI staining, cell-cycle distribution by flow cytometry, and caspase-3/7 activity by a flow cytometric assay. In addition, intracellular levels of the proteostasis-related proteins p97/VCP, SVIP, and p62/SQSTM1 were quantified by flow cytometry. Tomentosin reduced A549 cell viability in a dose- and time-dependent manner, with a 24 h IC50 value of 24.46 ± 1.61 µM, while producing a comparatively lower cytotoxic response in BEAS-2B cells. Tomentosin increased apoptotic cell populations and altered cell-cycle distribution. Combined exposure to tomentosin and cisplatin resulted in an early apoptotic population of 72.58 ± 0.47%, compared with 2.06 ± 0.11% in control cells, and was associated with greater caspase-3/7 activity than either treatment alone. Tomentosin and/or cisplatin also produced significant alterations in p97/VCP, SVIP, and p62 levels. These findings indicate that tomentosin exerts antiproliferative and pro-apoptotic effects in A549 cells and that combined exposure with cisplatin is associated with a greater biological response under the investigated in vitro conditions. The accompanying changes in p97/VCP, SVIP, and p62 suggest modulation of proteostasis-associated cellular responses; however, their functional contribution to the treatment response remains to be established.
- 1 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (10) , 1015
Open AccessTomentosin Potentiates Cisplatin-Induced Apoptosis and Modulates Proteostasis-Related Proteins in A549 Lung Cancer Cells
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the need for improved therapeutic strategies and adjunct treatment approaches. In this study, we investigated the anticancer effects of tomentosin in A549 cells and evaluated the cellular response to its combined exposure with cisplatin. Cell viability was assessed using the WST-1 assay in A549 and BEAS-2B cells. Apoptosis was evaluated by Annexin V-FITC/PI staining, cell-cycle distribution by flow cytometry, and caspase-3/7 activity by a flow cytometric assay. In addition, intracellular levels of the proteostasis-related proteins p97/VCP, SVIP, and p62/SQSTM1 were quantified by flow cytometry. Tomentosin reduced A549 cell viability in a dose- and time-dependent manner, with a 24 h IC50 value of 24.46 ± 1.61 µM, while producing a comparatively lower cytotoxic response in BEAS-2B cells. Tomentosin increased apoptotic cell populations and altered cell-cycle distribution. Combined exposure to tomentosin and cisplatin resulted in an early apoptotic population of 72.58 ± 0.47%, compared with 2.06 ± 0.11% in control cells, and was associated with greater caspase-3/7 activity than either treatment alone. Tomentosin and/or cisplatin also produced significant alterations in p97/VCP, SVIP, and p62 levels. These findings indicate that tomentosin exerts antiproliferative and pro-apoptotic effects in A549 cells and that combined exposure with cisplatin is associated with a greater biological response under the investigated in vitro conditions. The accompanying changes in p97/VCP, SVIP, and p62 suggest modulation of proteostasis-associated cellular responses; however, their functional contribution to the treatment response remains to be established.
- 15 September 2026
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 9 (5) , 176-185
Metabolic Syndrome Effects over Heart Tissue: A Histomorphological Glance under the Light of p97/VCP and SVIP
Metabolic syndrome(MetS) is a cluster of metabolic disorders that significantly increases the risk of heart disease and type 2 diabetes. p97/VCP (Valosin-Containing Protein), is an ATPase enzyme that regulates many vital processes in the cell such as cell cycle control, apoptosis, protein degradation, and cellular stress. Small VCP-interacting protein (SVIP) has various important functions in the cell which are particularly in the endoplasmic reticulum and proteasome systems. SVIP is a small but effective regulator of the protein recycling and quality control system in the cell. It affects processes such as cellular stress response, protein accumulation, and degradation, particularly through its interaction with the p97/VCP protein. MetS is one of the most important risk factors for cardiovascular diseases. However, the roles of p97/VCP and SVIP in cardiac tissue affected by MetS remain unclear. Therefore, this study aimed to investigate the histomorphological changes and the expression levels of p97/VCP and SVIP in rat heart tissue in a MetS model. The histomorphological alterations in heart tissues were evaluated using Hematoxylin-Eosin and Weigert Van Gieson staining methods. Using the immunohistochemical technique, the expression of p97/VCP and SVIP in rat heart tissue were examined. Statistical analyses were conducted and p
- 15 September 2026
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 9 (5) , 176-185
Metabolic Syndrome Effects over Heart Tissue: A Histomorphological Glance under the Light of p97/VCP and SVIP
Metabolic syndrome(MetS) is a cluster of metabolic disorders that significantly increases the risk of heart disease and type 2 diabetes. p97/VCP (Valosin-Containing Protein), is an ATPase enzyme that regulates many vital processes in the cell such as cell cycle control, apoptosis, protein degradation, and cellular stress. Small VCP-interacting protein (SVIP) has various important functions in the cell which are particularly in the endoplasmic reticulum and proteasome systems. SVIP is a small but effective regulator of the protein recycling and quality control system in the cell. It affects processes such as cellular stress response, protein accumulation, and degradation, particularly through its interaction with the p97/VCP protein. MetS is one of the most important risk factors for cardiovascular diseases. However, the roles of p97/VCP and SVIP in cardiac tissue affected by MetS remain unclear. Therefore, this study aimed to investigate the histomorphological changes and the expression levels of p97/VCP and SVIP in rat heart tissue in a MetS model. The histomorphological alterations in heart tissues were evaluated using Hematoxylin-Eosin and Weigert Van Gieson staining methods. Using the immunohistochemical technique, the expression of p97/VCP and SVIP in rat heart tissue were examined. Statistical analyses were conducted and p
- 21 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , 5521-5530
Does Creatine Improve Corticosteroid‐Mediated Facial Nerve Healing in a Rat Model?
Objective: To evaluate the effects of creatine monohydrate and methylprednisolone, administered individually or in combination, on functional and structural recovery following experimental facial nerve crush injury in rats. Methods: Forty Wistar albino rats were randomly allocated into five groups: control (Group 0), trauma only (Group 1), trauma plus creatine monohydrate (Group 2), trauma plus methylprednisolone (Group 3), and trauma plus combined therapy (Group 4). A standardized crush injury was induced in the marginal mandibular branch of the facial nerve. Electrophysiological assessments were performed pre‐injury, immediately after injury, and on postoperative Day 28. Histopathological evaluation was conducted using light and transmission electron microscopy. Results: Baseline and immediate post‐injury electrophysiological measurements were comparable among trauma groups. On postoperative Day 28, significant improvement in latency values and compound muscle action potentials (CMAPs) was observed in Groups 3 and 4 compared with post‐injury measurements ( p = 0.0001). Histopathological analysis demonstrated reduced myelin degeneration in Group 4 compared with Groups 1 and 2 ( p = 0.006 and p = 0.005). Endothelial morphology in Group 4 was comparable to Group 0, whereas increased endothelial cell height was observed in other trauma groups. Overall histomorphological recovery in Group 4 most closely resembled Group 0. Conclusion: Combined administration of creatine monohydrate and methylprednisolone resulted in superior histopathological recovery compared with monotherapy. While corticosteroids improved electrophysiological outcomes, the addition of creatine enhanced structural preservation, supporting its role as an adjunct therapy. Level of Evidence: N/A.
- 21 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , 5521-5530
Does Creatine Improve Corticosteroid‐Mediated Facial Nerve Healing in a Rat Model?
Objective: To evaluate the effects of creatine monohydrate and methylprednisolone, administered individually or in combination, on functional and structural recovery following experimental facial nerve crush injury in rats. Methods: Forty Wistar albino rats were randomly allocated into five groups: control (Group 0), trauma only (Group 1), trauma plus creatine monohydrate (Group 2), trauma plus methylprednisolone (Group 3), and trauma plus combined therapy (Group 4). A standardized crush injury was induced in the marginal mandibular branch of the facial nerve. Electrophysiological assessments were performed pre‐injury, immediately after injury, and on postoperative Day 28. Histopathological evaluation was conducted using light and transmission electron microscopy. Results: Baseline and immediate post‐injury electrophysiological measurements were comparable among trauma groups. On postoperative Day 28, significant improvement in latency values and compound muscle action potentials (CMAPs) was observed in Groups 3 and 4 compared with post‐injury measurements ( p = 0.0001). Histopathological analysis demonstrated reduced myelin degeneration in Group 4 compared with Groups 1 and 2 ( p = 0.006 and p = 0.005). Endothelial morphology in Group 4 was comparable to Group 0, whereas increased endothelial cell height was observed in other trauma groups. Overall histomorphological recovery in Group 4 most closely resembled Group 0. Conclusion: Combined administration of creatine monohydrate and methylprednisolone resulted in superior histopathological recovery compared with monotherapy. While corticosteroids improved electrophysiological outcomes, the addition of creatine enhanced structural preservation, supporting its role as an adjunct therapy. Level of Evidence: N/A.
- Open Access
- 4 March 2026
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 12 (1)
Impact of Metabolic Syndrome on SVIP and p97/VCP Expression in Renal Tissue
Objective: Metabolic syndrome (MetS) is a clinical condition in which a series of metabolic disorders occur together, increasing the risk of cardiovascular diseases and type 2 diabetes. p97/VCP is a member of the AAA+ ATPase protein family, which functions in various intracellular mechanisms. It plays a critical role, particularly in maintaining proteostasis and ERAD. SVIP is an adaptor protein found on the endoplasmic reticulum membrane. It can bind to p97/VCP and suppress its role in processes such as ERAD. MetS affects renal tissue through multifaceted mechanisms, increasing the risk of developing chronic kidney disease. This situation plays a key role in the development of diabetic nephropathy and hypertensive nephropathy in particular. Very little is known about the role of p97/VCP and SVIP in the MetS kidney. So, it is important to study p97/ VCP and SVIP in MetS kidney tissue.Material and Methods: Hematoxylin Eosin and Azan Trichrome stainings were used to examine the histomorphology of rat kidney tissue. The expression of p97/VCP and SVIP in tissue was investigated using immunohistochemistry.Results: Both the control and MetS kidney tissue showed signs of p97/VCP and SVIP expression. Comparing the two experimental groups, the MetS group showed higher SVIP expression and lower p97/VCP expression than the control group.Conclusion: Demonstrating the morphological alterations of the kidney in the control and MetS groups is crucial and histologically significant. Furthermore, SVIP and p97/VCP expressions in metabolic syndrome are significant for chronic renal disease. These results represent a significant advancement in our knowledge of the causes and consequences of metabolic syndrome.
- 4 March 2026
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 12 (1)
Open AccessImpact of Metabolic Syndrome on SVIP and p97/VCP Expression in Renal Tissue
Objective: Metabolic syndrome (MetS) is a clinical condition in which a series of metabolic disorders occur together, increasing the risk of cardiovascular diseases and type 2 diabetes. p97/VCP is a member of the AAA+ ATPase protein family, which functions in various intracellular mechanisms. It plays a critical role, particularly in maintaining proteostasis and ERAD. SVIP is an adaptor protein found on the endoplasmic reticulum membrane. It can bind to p97/VCP and suppress its role in processes such as ERAD. MetS affects renal tissue through multifaceted mechanisms, increasing the risk of developing chronic kidney disease. This situation plays a key role in the development of diabetic nephropathy and hypertensive nephropathy in particular. Very little is known about the role of p97/VCP and SVIP in the MetS kidney. So, it is important to study p97/ VCP and SVIP in MetS kidney tissue.Material and Methods: Hematoxylin Eosin and Azan Trichrome stainings were used to examine the histomorphology of rat kidney tissue. The expression of p97/VCP and SVIP in tissue was investigated using immunohistochemistry.Results: Both the control and MetS kidney tissue showed signs of p97/VCP and SVIP expression. Comparing the two experimental groups, the MetS group showed higher SVIP expression and lower p97/VCP expression than the control group.Conclusion: Demonstrating the morphological alterations of the kidney in the control and MetS groups is crucial and histologically significant. Furthermore, SVIP and p97/VCP expressions in metabolic syndrome are significant for chronic renal disease. These results represent a significant advancement in our knowledge of the causes and consequences of metabolic syndrome.
- 30 November 2025
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
DOES RETINOIC ACID PAVE A WAY FROM TESTICULAR EMBRYONAL CARCINOMA TO NEURON
Introduction: One kind of testicular cancer which affects germ cells that eventually give rise to sperm is called testicular embryonal carcinoma. These cancer cells can self-renew and differentiate, and they encourage the growth of malignancies. An active byproduct of vitamin A (retinol), retinoic acid (RA), is crucial for both embryonic development and fundamental biological functions such cell division, proliferation, and death. It is frequently utilized as a differentiation inducer in vitro, particularly on cancer and stem cells. S100B protein plays an important role in events such as inflammation, cell growth, cell differentiation, cytoskeleton dynamics and cell movement. NF-κB (nuclear factor kappa B) is a protein complex that is an important transcription factor within the cell. Constantly active NF-κB increases cell proliferation in some cancers and inhibits the immune system's response to the tumor. The aim of the study is to demonstrate how the morphology and S100B and NF-κB expressions of testicular embryonal carcinoma cells change as a result of RA stimulation. Method: After RA was administered to the testicular embryonal carcinoma cells (CRL-2073) at the determined dose (10 μM), crystal violet and luxol fast blue stainings were performed for morphological examination. Then, using immunohistochemical technique, cellular expression and location of S100B and NF-κB in testicular embryonal carcinoma cells were examined. Results: When we stained CRL-2073 cells differentiated with RA with crystal violet, we observed morphological differences in the cell nucleus and cytoplasm, which is a visual indicator of differentiation. Luxol fast blue staining was observed in CRL-2073 cells that began neuronal differentiation with RA. The S100B protein was expressed in embryonal carcinoma cells and was associated with cell differentiation. NF-κB was active in maintaining proliferation and pluripotency in these cells; its activity decreased with differentiation. Conclusion: It is important to show histologically that CRL-2073 cells begin to differentiate with RA. In addition, determining the expression levels of S100B and NF-κB proteins, which are biomarkers for both tumor biology and differentiation processes, by immunostaining before and after RA is a potential treatment target. This information is an important step in understanding cancer biology.
- 30 November 2025
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
DOES RETINOIC ACID PAVE A WAY FROM TESTICULAR EMBRYONAL CARCINOMA TO NEURON
Introduction: One kind of testicular cancer which affects germ cells that eventually give rise to sperm is called testicular embryonal carcinoma. These cancer cells can self-renew and differentiate, and they encourage the growth of malignancies. An active byproduct of vitamin A (retinol), retinoic acid (RA), is crucial for both embryonic development and fundamental biological functions such cell division, proliferation, and death. It is frequently utilized as a differentiation inducer in vitro, particularly on cancer and stem cells. S100B protein plays an important role in events such as inflammation, cell growth, cell differentiation, cytoskeleton dynamics and cell movement. NF-κB (nuclear factor kappa B) is a protein complex that is an important transcription factor within the cell. Constantly active NF-κB increases cell proliferation in some cancers and inhibits the immune system's response to the tumor. The aim of the study is to demonstrate how the morphology and S100B and NF-κB expressions of testicular embryonal carcinoma cells change as a result of RA stimulation. Method: After RA was administered to the testicular embryonal carcinoma cells (CRL-2073) at the determined dose (10 μM), crystal violet and luxol fast blue stainings were performed for morphological examination. Then, using immunohistochemical technique, cellular expression and location of S100B and NF-κB in testicular embryonal carcinoma cells were examined. Results: When we stained CRL-2073 cells differentiated with RA with crystal violet, we observed morphological differences in the cell nucleus and cytoplasm, which is a visual indicator of differentiation. Luxol fast blue staining was observed in CRL-2073 cells that began neuronal differentiation with RA. The S100B protein was expressed in embryonal carcinoma cells and was associated with cell differentiation. NF-κB was active in maintaining proliferation and pluripotency in these cells; its activity decreased with differentiation. Conclusion: It is important to show histologically that CRL-2073 cells begin to differentiate with RA. In addition, determining the expression levels of S100B and NF-κB proteins, which are biomarkers for both tumor biology and differentiation processes, by immunostaining before and after RA is a potential treatment target. This information is an important step in understanding cancer biology.
- 12 March 2025
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
A LOOK TO THE RELATIONSHIP BETWEEN AUTOPHAGY AND EMBRYONAL CARCINOMA FROM A DIFFERENT PERSPECTIVE
Introduction: Testicular embryonal carcinoma is a type of testicular cancer that affects the germ cells which are the precursors of sperm cells that will eventually develop into sperm. These carcinoma cells are often aggressive. In such cells, autophagy may promote the survival and proliferation of cancer cells, as autophagy can help cells survive under stress. Autophagy may also allow cancer cells to develop resistance to their environment and to metastasize. ATG4 (Autophagy related 4) is a protein that plays a role in the initiation of autophagy. JAB1 (Jun activation domain binding protein 1) is a protein involved in cellular signaling and regulates many biological processes such as cell cycle, apoptosis, and gene expression. JAB1 is also involved in the regulation of the p27 protein, and its high expression can be observed in cancer cells. NEDL2 (Neuroepithelial differentiation marker like 2) is involved in cellular growth and developmental processes. It is also a protein that is thought to play a role in cancer progression. The aim of the study was to demonstrate expression and localization of ATG4, JAB1 and NEDL2 in testicular embryonal carcinoma cells. Methods: The morphological examination of testis embryonal carcinoma cells were performed by using hematoxylin eosin (H-E) staining. Then, using the immunohistochemical technique, cellular expression and location of ATG4, JAB1 and NEDL2 in testis embryonal carcinoma cells were examined. Results: According to immunohistochemistry results, ATG4, JAB1 and NEDL2 expression was detected in human testicular embryonal carcinoma cells. Conclusions: By determining the expression levels of these three proteins, more information can be obtained about how important processes such as autophagy, cell cycle regulation and cellular development are affected in testicular embryonal carcinoma. This information could be an important step in understanding the biology of cancer and developing treatment strategies.
- 12 March 2025
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
A LOOK TO THE RELATIONSHIP BETWEEN AUTOPHAGY AND EMBRYONAL CARCINOMA FROM A DIFFERENT PERSPECTIVE
Introduction: Testicular embryonal carcinoma is a type of testicular cancer that affects the germ cells which are the precursors of sperm cells that will eventually develop into sperm. These carcinoma cells are often aggressive. In such cells, autophagy may promote the survival and proliferation of cancer cells, as autophagy can help cells survive under stress. Autophagy may also allow cancer cells to develop resistance to their environment and to metastasize. ATG4 (Autophagy related 4) is a protein that plays a role in the initiation of autophagy. JAB1 (Jun activation domain binding protein 1) is a protein involved in cellular signaling and regulates many biological processes such as cell cycle, apoptosis, and gene expression. JAB1 is also involved in the regulation of the p27 protein, and its high expression can be observed in cancer cells. NEDL2 (Neuroepithelial differentiation marker like 2) is involved in cellular growth and developmental processes. It is also a protein that is thought to play a role in cancer progression. The aim of the study was to demonstrate expression and localization of ATG4, JAB1 and NEDL2 in testicular embryonal carcinoma cells. Methods: The morphological examination of testis embryonal carcinoma cells were performed by using hematoxylin eosin (H-E) staining. Then, using the immunohistochemical technique, cellular expression and location of ATG4, JAB1 and NEDL2 in testis embryonal carcinoma cells were examined. Results: According to immunohistochemistry results, ATG4, JAB1 and NEDL2 expression was detected in human testicular embryonal carcinoma cells. Conclusions: By determining the expression levels of these three proteins, more information can be obtained about how important processes such as autophagy, cell cycle regulation and cellular development are affected in testicular embryonal carcinoma. This information could be an important step in understanding the biology of cancer and developing treatment strategies.
- 22 March 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (4) , 704.e1-704.e7
Foreskin neurovascular structure: A histological analysis comparing 0–3 years and 6–11 years children
- 22 March 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (4) , 704.e1-704.e7
Foreskin neurovascular structure: A histological analysis comparing 0–3 years and 6–11 years children
- Open Access
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 331-336
Kolorektal Kanserde Rapamisin ve Vemurafenib’in Apoptotik Etkilerinin Karşılaştırılması
Kolorektal kanser (KRK), dünyada en sık görülen üçüncü kanser türüdür. KRK’de ilk tedavi seçeneği cerrahi ve kemoterapidir. Ancak, kullanılan ilaçlara karşı gelişen direnç, uygulanan kemoterapinin başarısız olmasına yol açmaktadır. Son yıllarda yeni teröpatik ajan arayışları, KRK gelişimi ve ilerlemesinde rol oynayan farklı moleküler mekanizmalar üzerinde yoğunlaşmaktadır. mTOR ve MAPK sinyal yolaklarının KRK gelişiminde anahtar rol oynadığı bilinmektedir. Bu çalışmada, KRK hücrelerinde mTOR yolağı inhibitörü Rapamisin (RAPA) ve MAPK yolağı inhibitörü Vemurafenib (VMF)’in apoptoz üzerine olan etkilerinin karşılaştırılması amaçlanmıştır. Çalışmamızda, insan KRK hücrelerinde üretilen HT29 hücre hattı kültüre edilmiştir. RAPA ve VMF’nin HT29 KRK hücreleri üzerindeki uygun dozunun belirlenmesi için WST-1 testi ve apoptotik etkilerinin belirlenmesi amacıyla da akım sitometrisi yöntemi kullanılmıştır. İstatistiksel anlamlılık düzeyi p≤0.05 olarak kabul edilmiştir. Elde ettiğimiz verilere göre, HT29 hücrelerine uygulanacak olan RAPA ve VMF dozu 24. saatte sırasıyla 46,97 μM ve 35,84 μM olarak bulunmuştur. HT29 hücrelerinde RAPA’nın apoptotik süreç üzerinde VMF’den daha etkin olduğu bulunmuştur (RAPA için; p
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 331-336
Open AccessKolorektal Kanserde Rapamisin ve Vemurafenib’in Apoptotik Etkilerinin Karşılaştırılması
Kolorektal kanser (KRK), dünyada en sık görülen üçüncü kanser türüdür. KRK’de ilk tedavi seçeneği cerrahi ve kemoterapidir. Ancak, kullanılan ilaçlara karşı gelişen direnç, uygulanan kemoterapinin başarısız olmasına yol açmaktadır. Son yıllarda yeni teröpatik ajan arayışları, KRK gelişimi ve ilerlemesinde rol oynayan farklı moleküler mekanizmalar üzerinde yoğunlaşmaktadır. mTOR ve MAPK sinyal yolaklarının KRK gelişiminde anahtar rol oynadığı bilinmektedir. Bu çalışmada, KRK hücrelerinde mTOR yolağı inhibitörü Rapamisin (RAPA) ve MAPK yolağı inhibitörü Vemurafenib (VMF)’in apoptoz üzerine olan etkilerinin karşılaştırılması amaçlanmıştır. Çalışmamızda, insan KRK hücrelerinde üretilen HT29 hücre hattı kültüre edilmiştir. RAPA ve VMF’nin HT29 KRK hücreleri üzerindeki uygun dozunun belirlenmesi için WST-1 testi ve apoptotik etkilerinin belirlenmesi amacıyla da akım sitometrisi yöntemi kullanılmıştır. İstatistiksel anlamlılık düzeyi p≤0.05 olarak kabul edilmiştir. Elde ettiğimiz verilere göre, HT29 hücrelerine uygulanacak olan RAPA ve VMF dozu 24. saatte sırasıyla 46,97 μM ve 35,84 μM olarak bulunmuştur. HT29 hücrelerinde RAPA’nın apoptotik süreç üzerinde VMF’den daha etkin olduğu bulunmuştur (RAPA için; p